Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension
NCT ID: NCT00185133
Last Updated: 2018-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1900 participants
INTERVENTIONAL
2005-05-31
2007-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension
NCT00649389
Amlodipine as add-on to Olmesartan in Hypertension
NCT00220220
Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension
NCT00527514
18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics
NCT00654745
Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension
NCT00923091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Olmesartan medoxomil
Amlodipine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older (20% equal to or older than 65 years)
* With mild to severe hypertension defined as seated diastolic blood pressure of 95-120 mmHg while off any hypertensive medication
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Daiichi Sankyo
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daiichi Sankyo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham, Alabama, United States
Huntsville, Alabama, United States
Mobile, Alabama, United States
Muscle Shoals, Alabama, United States
Tuscumbia, Alabama, United States
Phoenix, Arizona, United States
Tucson, Arizona, United States
Little Rock, Arkansas, United States
Anaheim, California, United States
Beverly Hills, California, United States
Buena Park, California, United States
Cypress, California, United States
Encino, California, United States
Fountain Valley, California, United States
La Jolla, California, United States
Long Beach, California, United States
Los Angeles, California, United States
Los Gatos, California, United States
Pico Rivera, California, United States
Rancho Mirage, California, United States
Roseville, California, United States
Sacramento, California, United States
San Francisco, California, United States
Santa Ana, California, United States
Spring Valley, California, United States
Temecula, California, United States
Tustin, California, United States
Walnut Creek, California, United States
Golden, Colorado, United States
Bristol, Connecticut, United States
Stratford, Connecticut, United States
Newark, Delaware, United States
Washington D.C., District of Columbia, United States
Clearwater, Florida, United States
Coral Gables, Florida, United States
Daytona Beach, Florida, United States
DeLand, Florida, United States
Fort Lauderdale, Florida, United States
Hialeah, Florida, United States
Hollywood, Florida, United States
Jacksonville, Florida, United States
Kissimmee, Florida, United States
Merritt Island, Florida, United States
Miami, Florida, United States
New Port Richey, Florida, United States
Ocala, Florida, United States
Orlando, Florida, United States
Palm Harbor, Florida, United States
Pembroke Pines, Florida, United States
Pinellas Park, Florida, United States
Sarasota, Florida, United States
Sebastian, Florida, United States
Stuart, Florida, United States
Tamarac, Florida, United States
West Palm Beach, Florida, United States
Atlanta, Georgia, United States
Blairsville, Georgia, United States
Boise, Idaho, United States
Chicago, Illinois, United States
Evansville, Indiana, United States
Indianapolis, Indiana, United States
Arkansas City, Kansas, United States
Shawnee Mission, Kansas, United States
Erlanger, Kentucky, United States
New Orleans, Louisiana, United States
Shreveport, Louisiana, United States
Auburn, Maine, United States
Oxon Hill, Maryland, United States
Benzonia, Michigan, United States
Cadillac, Michigan, United States
Livonia, Michigan, United States
Troy, Michigan, United States
Brooklyn Center, Minnesota, United States
Olive Branch, Mississippi, United States
Kansas City, Missouri, United States
Butte, Montana, United States
Omaha, Nebraska, United States
Henderson, Nevada, United States
Berlin, New Jersey, United States
Elizabeth, New Jersey, United States
Hackensack, New Jersey, United States
South Bound Brook, New Jersey, United States
Turnersville, New Jersey, United States
East Syracuse, New York, United States
Manlius, New York, United States
Rochester, New York, United States
Kinston, North Carolina, United States
Raleigh, North Carolina, United States
Salisbury, North Carolina, United States
Statesville, North Carolina, United States
Wilmington, North Carolina, United States
Winston-Salem, North Carolina, United States
Cincinnati, Ohio, United States
Columbus, Ohio, United States
Lyndhurst, Ohio, United States
Marion, Ohio, United States
Mogadore, Ohio, United States
Oklahoma City, Oklahoma, United States
Tulsa, Oklahoma, United States
Eugene, Oregon, United States
Portland, Oregon, United States
Beaver, Pennsylvania, United States
Bensalem, Pennsylvania, United States
Downingtown, Pennsylvania, United States
Feasterville, Pennsylvania, United States
Fleetwood, Pennsylvania, United States
Lansdale, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Uniontown, Pennsylvania, United States
Cranston, Rhode Island, United States
Anderson, South Carolina, United States
Charleston, South Carolina, United States
Greer, South Carolina, United States
Mt. Pleasant, South Carolina, United States
Simpsonville, South Carolina, United States
Bristol, Tennessee, United States
Nashville, Tennessee, United States
New Tazewell, Tennessee, United States
Arlington, Texas, United States
Austin, Texas, United States
Carrollton, Texas, United States
Corpus Christi, Texas, United States
Dallas, Texas, United States
Fort Worth, Texas, United States
Houston, Texas, United States
Lake Jackson, Texas, United States
Midland, Texas, United States
New Braunfels, Texas, United States
San Angelo, Texas, United States
San Antonio, Texas, United States
Salt Lake City, Utah, United States
Burke, Virginia, United States
Norfolk, Virginia, United States
Richmond, Virginia, United States
Suffolk, Virginia, United States
Lakewood, Washington, United States
Olympia, Washington, United States
Charleston, West Virginia, United States
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CS8663-A-U301
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.